Skip to content

Self-Management of Chronic Depressive Symptoms in Pregnancy

Self-Management of Chronic Depressive Symptoms in Pregnancy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02953990
Enrollment
41
Registered
2016-11-03
Start date
2016-09-30
Completion date
2019-02-12
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Pregnancy, Self-Management, Yoga

Brief summary

This study will provide information about the feasibility, acceptability, and preliminary effects of a biobehavioral self-management approach for perinatal depressive symptoms. This line of research will contribute to the body of knowledge about adjunctive therapies for depressive symptoms in pregnancy, a serious problem which contributes to poor maternal-child outcomes. Ultimately, this will contribute to the development and implementation of theoretically driven depression prevention/ resiliency building interventions and measurement of appropriate biobehavioral outcomes to determine the effectiveness of interventions.

Detailed description

The investigators longitudinal mixed-methods study will use a one-group repeated measures intervention design coupled with qualitative methods to provide a comprehensive view of the feasibility, acceptability, and preliminary effects of the MOMS intervention. Semi-structured interviews, recruitment and retention numbers, and participant logs will be used to evaluate feasibility and acceptability of the intervention (Specific Aim 1). Recently collected archival comparison group data from an existing study will be used to contribute to explorations of preliminary effects of the intervention by comparing longitudinal psychobehavioral data, birth weight data (Specific Aims 2 and 3).

Interventions

BEHAVIORALMOMS Program

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ age 18; * self-report of depressive symptoms prior to pregnancy; * current depressive symptoms at a moderate-to-severe level, as defined by a score ≥10 on the Patient Health Questionnaire-9; * able to read, write, and understand English; * self-identify as black/African American (AA) or White; * absence of suicidal ideations (measured as low risk on the M.I.N.I. Neuropsychiatric Interview tool); * absence of pregnancy complications/physical conditions making physical activity (PA) inadvisable; * has not engaged in a consistent mindfulness-based PA routine during the pregnancy (such as yoga or similar activities more than once per month).

Exclusion criteria

* If individual does not meet the inclusion criteria listed above, they are ineligible for the study.

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Databaseline\# individuals who enrolled in study/ # individuals who expressed interest in the study
Retention Data18 weeks post-baseline\# of participants enrolled/ # of participants completing study
AdherenceEnd of 12 week interventionMeasure of those who attended at least 50% of the yoga sessions (measured analyzing class rosters)
Completed InterviewsEnd of 6 week postpartum visitThe number of participants who completed the intervention and completed a postpartum semi-structured interview
Edinburgh Postnatal Depression Scale (EPDS)baseline and end of 12 week interventionPregnancy-specific Depressive Symptoms/Perinatal-specific depressive symptoms were measured by the 10-item Edinburgh Postnatal Depression Scale (EPDS; Cox et al., 1987); scores range from0 to 30, and a score of≥10 is considered indicative of possible depressive symptoms.

Secondary

MeasureTime frameDescription
Baby's Birth Weightpostpartum visitBaby's birth weight in pounds per mother's report at postpartum visit
Patient Health Questionnaire-9 (PHQ9)baseline and end of 12 week interventionDepressive Symptoms/ Perceived stress was measured with the 10-item Perceived Stress Scale; scores range from 0 to 40, and higher scores represent higher perceived stress.
Total # of Minutes in Physical Activity (Including Yoga)End of 12 week interventionAdherence to physical activity aspect of intervention (including yoga)
StressChange from Baseline visit to end of 12 week intervention visitPerceived Stress Scale (PSS): 10-item scale; scores range from 0 to 40, and higher scores represent higher perceived stress
State-Trait Anxiety Inventory-State (STAI-S)baseline and at the end of the 12 week interventionState Anxiety/ Anxiety was measured with the State Anxiety Form Y ; scores range from20 to 80, and higher scores indicate higher state anxiety.
Ruminations Response Scale (RRS-10)baseline and at the end of the 12 week interventionRuminations/ The Ruminative Responses Scale was used to measure ruminations; total scores range from 10 to 40, where higher scores indicate higher rumination.
Self-Efficacy for Physical ActivityBaseline visit to end of 12 week intervention visitSelf-Efficacy for Physical Activity: The Physical Activity Self-Efficacy Scale is an eight-question scale that contains items about self-management of physical activities and social support regarding physical activity. A higher score indicates higher self-efficacy. The scores may range form 0-90
Maternal Fetal Attachment Scale (MFAS)baseline and at the end of the 12 week interventionMaternal-Child Attachment/ Maternal-fetal/ child attachment was measured using the Maternal-Fetal Attachment Scale with wording adapted slightly for the postpartum use; scores range from 24 to 120,with higher scores indicating higher attachment.

Countries

United States

Participant flow

Participants by arm

ArmCount
MOMS Program
The MOMS Program involves: (1) mindfulness of symptoms and goal-setting through a nurse-participant partnership, and (2) 12 weeks of weekly community-based group prenatal yoga classes (75 minutes each) and self-directed home activity. Participants will engage in 12 weeks of weekly community-based group prenatal yoga classes (75 minutes each) and self-directed home practice. MOMS Program
41
Total41

Baseline characteristics

CharacteristicMOMS Program
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
41 Participants
Age, Continuous29.10 years
STANDARD_DEVIATION 5.32
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
26 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
12 Participants
Region of Enrollment
United States
41 participants
Sex: Female, Male
Female
41 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 41
other
Total, other adverse events
0 / 41
serious
Total, serious adverse events
0 / 41

Outcome results

Primary

Adherence

Measure of those who attended at least 50% of the yoga sessions (measured analyzing class rosters)

Time frame: End of 12 week intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MOMS ProgramAdherence26 Participants
Primary

Completed Interviews

The number of participants who completed the intervention and completed a postpartum semi-structured interview

Time frame: End of 6 week postpartum visit

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MOMS ProgramCompleted Interviews26 Participants
Primary

Edinburgh Postnatal Depression Scale (EPDS)

Pregnancy-specific Depressive Symptoms/Perinatal-specific depressive symptoms were measured by the 10-item Edinburgh Postnatal Depression Scale (EPDS; Cox et al., 1987); scores range from0 to 30, and a score of≥10 is considered indicative of possible depressive symptoms.

Time frame: baseline and end of 12 week intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOMS ProgramEdinburgh Postnatal Depression Scale (EPDS)Baseline15.2 score on a scaleStandard Deviation 0.86
MOMS ProgramEdinburgh Postnatal Depression Scale (EPDS)End of Intervention5.05 score on a scaleStandard Deviation 0.67
Primary

Recruitment Data

\# individuals who enrolled in study/ # individuals who expressed interest in the study

Time frame: baseline

Population: 41 enrolled/ 50 eligible

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MOMS ProgramRecruitment Data41 Participants
Primary

Retention Data

\# of participants enrolled/ # of participants completing study

Time frame: 18 weeks post-baseline

Population: 41 enrolled/ 27 completed

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MOMS ProgramRetention Data27 Participants
Secondary

Baby's Birth Weight

Baby's birth weight in pounds per mother's report at postpartum visit

Time frame: postpartum visit

ArmMeasureValue (MEAN)Dispersion
MOMS ProgramBaby's Birth Weight7.57 poundsStandard Deviation 1.33
Secondary

Maternal Fetal Attachment Scale (MFAS)

Maternal-Child Attachment/ Maternal-fetal/ child attachment was measured using the Maternal-Fetal Attachment Scale with wording adapted slightly for the postpartum use; scores range from 24 to 120,with higher scores indicating higher attachment.

Time frame: baseline and at the end of the 12 week intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOMS ProgramMaternal Fetal Attachment Scale (MFAS)Baseline54.56 score on a scaleStandard Deviation 2.51
MOMS ProgramMaternal Fetal Attachment Scale (MFAS)End of intervention43.97 score on a scaleStandard Deviation 2.01
Secondary

Patient Health Questionnaire-9 (PHQ9)

Depressive Symptoms/ Perceived stress was measured with the 10-item Perceived Stress Scale; scores range from 0 to 40, and higher scores represent higher perceived stress.

Time frame: baseline and end of 12 week intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOMS ProgramPatient Health Questionnaire-9 (PHQ9)Baseline13.54 score on a scaleStandard Deviation 0.4
MOMS ProgramPatient Health Questionnaire-9 (PHQ9)End of intervention5.05 score on a scaleStandard Deviation 0.67
Secondary

Ruminations Response Scale (RRS-10)

Ruminations/ The Ruminative Responses Scale was used to measure ruminations; total scores range from 10 to 40, where higher scores indicate higher rumination.

Time frame: baseline and at the end of the 12 week intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOMS ProgramRuminations Response Scale (RRS-10)Baseline26.63 score on a scaleStandard Deviation 1.08
MOMS ProgramRuminations Response Scale (RRS-10)End of intervention23.14 score on a scaleStandard Deviation 1.29
Secondary

Self-Efficacy for Physical Activity

Self-Efficacy for Physical Activity: The Physical Activity Self-Efficacy Scale is an eight-question scale that contains items about self-management of physical activities and social support regarding physical activity. A higher score indicates higher self-efficacy. The scores may range form 0-90

Time frame: Baseline visit to end of 12 week intervention visit

ArmMeasureGroupValue (MEAN)Dispersion
MOMS ProgramSelf-Efficacy for Physical Activitybaseline26.04 score on a scaleStandard Deviation 7.4
MOMS ProgramSelf-Efficacy for Physical Activityend of intervention28.6 score on a scaleStandard Deviation 7.8
Secondary

State-Trait Anxiety Inventory-State (STAI-S)

State Anxiety/ Anxiety was measured with the State Anxiety Form Y ; scores range from20 to 80, and higher scores indicate higher state anxiety.

Time frame: baseline and at the end of the 12 week intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOMS ProgramState-Trait Anxiety Inventory-State (STAI-S)Baseline50.02 score on a scaleStandard Deviation 2.1
MOMS ProgramState-Trait Anxiety Inventory-State (STAI-S)End of intervention36.04 score on a scaleStandard Deviation 2.1
Secondary

Stress

Perceived Stress Scale (PSS): 10-item scale; scores range from 0 to 40, and higher scores represent higher perceived stress

Time frame: Change from Baseline visit to end of 12 week intervention visit

ArmMeasureGroupValue (MEAN)Dispersion
MOMS ProgramStressBaseline25.27 score on a scaleStandard Deviation 0.89
MOMS ProgramStressEnd of intervention16.72 score on a scaleStandard Deviation 1.17
Secondary

Total # of Minutes in Physical Activity (Including Yoga)

Adherence to physical activity aspect of intervention (including yoga)

Time frame: End of 12 week intervention

ArmMeasureValue (MEAN)
MOMS ProgramTotal # of Minutes in Physical Activity (Including Yoga)141 minutes per week

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026